These cell lines were chosen because of their gene mutations, which are the most frequently occurring in NSCLC patients, e.g., A549: mutations in the KRAS gene; H1975: mutations in the EGFR gene; and H1703; mutations in the Tp53 gene. Here, TP53 is linked to non-small cell lung carcinoma.